Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.3 - $3.73 $4,439 - $55,200
14,799 New
14,799 $5,000
Q1 2022

May 16, 2022

SELL
$0.37 - $1.0 $77,798 - $210,266
-210,266 Reduced 55.07%
171,536 $76,000
Q4 2021

Feb 14, 2022

BUY
$0.95 - $1.72 $144,799 - $262,164
152,421 Added 66.45%
381,802 $363,000
Q3 2021

Nov 15, 2021

BUY
$1.68 - $2.88 $305,366 - $523,486
181,766 Added 381.74%
229,381 $388,000
Q2 2021

Aug 11, 2021

BUY
$1.88 - $3.56 $7,871 - $14,905
4,187 Added 9.64%
47,615 $133,000
Q1 2021

May 17, 2021

BUY
$1.47 - $3.29 $47,779 - $106,934
32,503 Added 297.51%
43,428 $97,000
Q4 2020

Feb 16, 2021

SELL
$1.36 - $1.75 $10,765 - $13,853
-7,916 Reduced 42.01%
10,925 $16,000
Q2 2020

Aug 14, 2020

SELL
$1.69 - $2.79 $9,967 - $16,455
-5,898 Reduced 23.84%
18,841 $39,000
Q1 2020

May 15, 2020

SELL
$1.59 - $3.35 $54,646 - $115,136
-34,369 Reduced 58.15%
24,739 $47,000
Q4 2019

Feb 14, 2020

BUY
$2.68 - $4.85 $16,018 - $28,988
5,977 Added 11.25%
59,108 $170,000
Q3 2019

Nov 14, 2019

SELL
$4.1 - $9.0 $32,816 - $72,036
-8,004 Reduced 13.09%
53,131 $271,000
Q2 2019

Aug 16, 2019

BUY
$5.15 - $7.92 $94,842 - $145,854
18,416 Added 43.11%
61,135 $484,000
Q2 2019

Aug 14, 2019

SELL
$5.15 - $7.92 $174,281 - $268,020
-33,841 Reduced 44.2%
42,719 $338,000
Q1 2019

May 15, 2019

BUY
$5.1 - $6.71 $286,104 - $376,424
56,099 Added 274.18%
76,560 $505,000
Q4 2018

Feb 14, 2019

BUY
$4.2 - $9.74 $85,936 - $199,290
20,461 New
20,461 $114,000

Others Institutions Holding MRKR

About Marker Therapeutics, Inc.


  • Ticker MRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,599,200
  • Market Cap $134M
  • Description
  • Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...
More about MRKR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.